Achilles therapeutics appoints julie o'neill to board of directors and markwin velders, ph.d. joins scientific advisory board

London, united kingdom, may 03, 2021 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing precision t cell therapies to treat solid tumors, today announces the appointment of julie o'neill as a non-executive director to the board and markwin velders, ph.d. to its scientific advisory board (sab). both individuals come to achilles with strong track records of experience in cell therapy and cell therapy manufacturing.
ACHL Ratings Summary
ACHL Quant Ranking